PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clayton R et al. – Beta–blockers and NSAIDS are associated with LP, suggesting that withdrawal of these drugs should be considered. Further studies are needed to confirm or refute the inverse relationship between mucosal LP and use of ACE inhibitors.

Related Articles

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09    Relevance Score: 67%

Cyclosporine in the management of esophageal lichen planus
Canadian Journal of Gastroenterology, 10/12/09    Relevance Score: 66%

Lichen planus in childhood: report of 100 cases
Clinical and Experimental Dermatology, 11/10/09    Relevance Score: 65%

Management of Symptomatic Esophageal Involvement With Lichen Planus
Journal of Clinical Gastroenterology, 10/21/09    Relevance Score: 65%

Basement membrane changes in lichen planopilaris
Journal of the European Academy of Dermatology and Venereology, 10/27/09    Relevance Score: 42%

Today in Clinical Pharmacology...keeping you current

Prasugrel for acute coronary syndromes: Faster, more potent, but higher bleeding risk รข?? Cleveland Clinic Journal of Medicine
Cleveland Clinic Journal of Medicine, 12/04/09

Q: Is an ACE inhibitor plus an ARB more effective than either drug alone?
Cleveland Clinic Journal of Medicine, 12/04/09

Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients
Scandinavian Journal of Pain, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address